Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer.
about
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastasesTargeting bone metabolism in patients with advanced prostate cancer: current options and controversies.Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases.Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience.Therapeutic management of bone metastasis in prostate cancer: an update.Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer.A systematic review of the impact of pain on overall survival in patients with cancer.The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population.Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.Prognostic value of biochemical variables for survival after surgery for metastatic bone disease of the extremities.Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer.A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with 223Radium-dichloride.Bisphosphonates for advanced prostate cancer.Estimation of the Most Influential Factors for Survival Probability Prediction of Prostate Cancer Patients.Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion.Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).Factors affecting (223)Ra therapy: clinical experience after 532 cycles from a single institution.Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.
P2860
Q30277291-14C4BD99-7589-4A22-B191-DEF98E52BA69Q33608134-860A9410-5347-4D91-B418-CB9740E3F1A3Q33689314-52C718D0-5F4D-43F2-9B10-1FE17E766FC3Q35087364-A09E312A-DEE7-4A49-A233-ECAA41F009A1Q36407003-FCC8C2B3-0F7F-4FE5-8468-A46F7B4CAF69Q36510928-719CAC05-C021-49EA-9228-D782966A5085Q37261280-4984CAA0-0B61-49EC-B41D-87EFB2BEFDC3Q38664856-7D4B3A4B-A44C-4629-8590-3A3359FEB508Q38777682-A1CED34E-C4BA-4CA4-BF4F-A98F54A16035Q38845259-F5243847-50CE-4BFF-B392-3EABB30AF572Q38964037-DC61FEEC-C2AC-487D-BC24-47212575AB7FQ39072065-4EEF98AD-8C42-482E-B023-F45154C38E7AQ39132056-204BD613-180C-4256-96E1-9A371CBFD703Q39344925-199A1405-2873-4230-9303-92D7AB244683Q39357548-8875DAD2-FF1B-4894-AD69-846CF0EE4037Q40407387-4A362237-CF79-4B89-BC62-526775760340Q47163242-A443D038-251B-4CD9-AB18-EDBB99C803CDQ47236071-7C16EA26-3EC2-44F5-9906-C5880784C66DQ47248454-4A115F20-ECE4-4AA1-BF9F-E544986530CEQ47549224-5099A21D-D88D-470F-AFCD-661EFE235FCCQ48138310-46B11BA3-0890-49FC-9FAA-91F29B494A89Q49573645-7772DBFD-2874-422D-9DE4-5BC8F68E26E0Q52676556-FA29DC33-05A3-4B52-8A3C-072944CE5BF7Q53328506-55322214-EAF8-48F7-9076-0FB9F9EBDD5BQ54940744-295B6143-2208-4E91-A7BE-CEE97C1927D4
P2860
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@en
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@nl
type
label
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@en
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@nl
prefLabel
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@en
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@nl
P2093
P1433
P1476
Bone-related Parameters are th ...... ion-resistant Prostate Cancer.
@en
P2093
Carsten Goessl
Christophe Massard
Janet Brown
Lawrence Karsh
Matthew Smith
Michael Carducci
Michael Rader
Neal Shore
Piotr Milecki
P356
10.1016/J.EURURO.2014.10.001
P407
P50
P577
2014-10-29T00:00:00Z